Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated to v3.4.1; previous revision v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-04T23:33:51.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary) and introduced labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Updated the page revision to v3.4.0, and removed the former wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T21:24:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The study status updated to Active, not recruiting (revision v3.3.4). A large portion of investigator contact information and names was removed from the page.
    Difference
    9%
    Check dated 2026-01-14T04:15:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added a new 'Locations' section listing recruitment sites across Colorado, District of Columbia, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Texas, Virginia, and Washington; revision updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T20:40:46.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2. This appears to be a minor metadata update with no changes to study content or displayed details.
    Difference
    0.0%
    Check dated 2025-11-25T11:00:20.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The government funding notice has been removed from the page. All study details, contacts, and locations remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-18T06:59:22.000Z thumbnail image

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.